LIGAND PHARMACEUTICALS INC ($LGND)
Reardon Andrew โ CLO & Secretary
Shares
8,810
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 26, 2026
EPS:Est: 1.46
Revenue:Est: $55.59M
Transaction Details
| Insider | Reardon Andrew |
|---|---|
| Title | CLO & Secretary |
| Transaction Date | Feb 14, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 14, 2026 |
| Shares Purchased | 8,810 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 43,338 |
| Derivative | No |
| Accession Number | 0002001011-26-000013 |
| Document | View SEC Filing |